BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28159233)

  • 1. Expression and activation of platelet-derived growth factor β receptor, mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) and extracellular signal-regulated kinase (ERK) in canine mammary tumours.
    Altamura G; Uberti BD; Galiero G; Martano M; Pirro A; Russo M; Borzacchiello G
    Res Vet Sci; 2017 Feb; 110():29-33. PubMed ID: 28159233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.
    Gattino F; Maniscalco L; Iussich S; Biasato I; Martano M; Morello E; Gola C; Millán Ruiz Y; Saeki N; Buracco P; Martín de Las Mulas J; De Maria R
    Vet Rec; 2018 Aug; 183(7):221. PubMed ID: 29440590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated platelet-derived growth factor β receptor and Ras-mitogen-activated protein kinase pathway in natural bovine urinary bladder carcinomas.
    Corteggio A; Di Geronimo O; Roperto S; Roperto F; Borzacchiello G
    Vet J; 2012 Mar; 191(3):393-5. PubMed ID: 21546288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor.
    Taylor CC
    Endocrinology; 2000 Apr; 141(4):1545-53. PubMed ID: 10746662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase expression analyses in canine mammary gland tumours - A pilot study.
    Koltai Z; Szabó B; Jakus J; Vajdovich P
    Acta Vet Hung; 2018 Jun; 66(2):294-308. PubMed ID: 29958529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of expression of ABCB1 and LRP genes by mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and its role in generation of side population cells in canine lymphoma cell lines.
    Tomiyasu H; Watanabe M; Goto-Koshino Y; Fujino Y; Ohno K; Sugano S; Tsujimoto H
    Leuk Lymphoma; 2013 Jun; 54(6):1309-15. PubMed ID: 23167606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
    Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
    Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling.
    Rybicka A; Mucha J; Majchrzak K; Taciak B; Hellmen E; Motyl T; Krol M
    J Physiol Pharmacol; 2015 Feb; 66(1):29-37. PubMed ID: 25716962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma.
    Ammoun S; Flaiz C; Ristic N; Schuldt J; Hanemann CO
    Cancer Res; 2008 Jul; 68(13):5236-45. PubMed ID: 18593924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
    Ahmed KM; Dong S; Fan M; Li JJ
    Mol Cancer Res; 2006 Dec; 4(12):945-55. PubMed ID: 17189385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
    Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
    Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
    Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of FOXP3 expression in canine mammary gland tumours.
    Oh SY; Ryu HH; Yoo DY; Hwang IK; Kweon OK; Kim WH
    Vet Comp Oncol; 2014 Mar; 12(1):20-8. PubMed ID: 22541038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.